Table 1.
Case | Cell type | Location | No. of EBV PCR-positive samples/samples analyzed* | No. of V genes
|
% of cells (rearrangements†) with mutated V genes‡ | % of cells (rearrangements†) assigned to clones | Clones with mutated V genes/total no. of clones | Intraclonal V gene diversity | ||
---|---|---|---|---|---|---|---|---|---|---|
VH | Vκ | Vλ | ||||||||
1 | EBER+ | GC1 | 30 /47 | 16 | 1 | 100 | 94 | 1 /1 | ||
IFR§ | 47 /68 | 18 | 100 | 100 | 1 /1 | |||||
All | 77 /115 | 34 | 1 | 100 | 97 | 1 /1¶ | No | |||
2 | GC2 | 11 /32 | 4 | 4 | 4 | 84 | 67 | 3 /3 | ||
GC3 | 17 /28 | 7 | 11 | 5 | 100 | 73 | 6 /6 | |||
IFR§ | 114 /180 | 59 | 40 | 34 | 95 | 63 | 15 /15 | |||
All | 142 /240 | 70 | 55 | 43 | 95 | 64∥ | 17 /17¶ | No | ||
1 | EBER−† | GC1 | 0 /45 | 13 | 16 | 11 | 66 | 20 | 3 /3 | Yes |
2 | GC2 | 0 /38 | 19 | 12 | 9 | 91 | 50∥ | 6 /6 | Yes | |
GC3 | 3 /40 | 9 | 11 | 5 | 42 | 4 | 0 /1** | ? | ||
Mantle of GC2 | 0 /22 | 14 | 12 | 12 | 10 | 0 | 0 /0 | |||
Mantle of GC3 | 0 /16 | 8 | 10 | 7 | 0 | 8 | 0 /1 | No | ||
Controls | ||||||||||
1 | B cells‡‡ | 11 /23 | 7 | 6 | 7 | 100 | 46 | 1 /1 | No | |
T cells‡‡ | 4 /36 | 4†† | 1†† | 1†† | ||||||
Buffer | 0 /41 | 0 | 0 | 0 | ||||||
2 | Buffer | 0 /59 | 0 | 0 | 0 |
Samples of case 1 and case 2 were analyzed for the presence of a fragment of the EBNA1 and LF2 gene, respectively. For EBV+ cells the efficiencies of EBV-specific PCRs are expected to vary between 40% and 70% because of technical matters such as DNA instability and loss of cells during transfer into reaction tubes.
Because groups of three to five EBER− cells were isolated, numbers given for these samples refer to the number of rearrangements amplified.
Disregarding nonfunctional Vκ gene rearrangements, which are usually inactivated and hence exempted from somatic hypermutation.
Including some EBER+ cells located at the border of GCs. To avoid wrong assignment of these cells to the GCs, they were counted as cells from the IFR.
Members of individual clones were located inside, as well as outside, GCs.
From four members of two clones, unique V gene rearrangements were amplified that are incompatible with the clonal rearrangements obtained from other cells of these clones, indicating a low level of cellular contamination. These samples were not taken into further consideration.
For one clone consisting of a member isolated from GC2 and a member from GC3, only one member harbored somatic mutations in the clonal V gene rearrangement.
CD20+ B cells and CD3+ T cells were isolated from sections adjacent to sections from which EBER+ and EBER− cells were micromanipulated.
The four VH and the two Vλ gene rearrangements originate from four T cell samples. Although this indicates a low level of cellular contamination in the analysis, the reliability of the results is demonstrated by (i) the higher frequency of PCR products from EBER+ cells (30–43%) compared with the T cell samples (11%, data not shown), (ii) the lack of PCR products from 100 buffer controls, (iii) the very low frequency of EBV PCR products (2%) obtained from EBER− samples, and (iv) the fact that all V gene PCR-positive samples of EBER+ cells from case 1 were indeed positive in the EBV PCR.